Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
-
Lithium Argentina Reports Second Quarter 2025 Results
-
Kinross Files Early Warning Report with respect to Asante Gold
-
SCARLET ROYAL LIMITED WINS BIG AT GLOBAL BRANDS AWARDS 2025
-
Two Prominent Professors to Keynote 25th Annual Neurotech Leaders Forum
-
Perion Reports Second Quarter 2025 Results
-
Joe Coin ($JOE) Makes Meme Coin History with Acquisition of Iconic 20-Year-Old ‘EmotiGuy’ IP
-
Air Docs Heating & Cooling provides backpacks and school supplies for Vero Beach Elementary School
-
Milwaukee Flooding: U-Haul Offers Disaster Relief at 11 Stores in SE Wisconsin
-
Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week
-
SkyWater Announces Participation in Upcoming Investor Conferences
-
Plum Role Model™ Named a 2025 Top HR Product of the Year by HR Executive
-
David Energy Taps VertexOne to Transform Customer Experience and Enable Clean Grid Goals
-
CleanSpark Appoints Matt Schultz CEO
-
Olive Resource Capital Provides Update on Investments for July 2025
-
Mines d'Or Orbec Appoints Jean-David Moore to Advisory Role
-
Gladiator Discovers New Zone in First Drilling Below 200m at Cowley
-
Toogood Gold Commences GPR Survey at the Quinlan Gold Discovery, Toogood Gold Project, Newfoundland
-
Sailfish Announces Normal Course Issuer Bid and Closes the Conversion of Gavilanes into a 2% NSR
-
Denarius Metals Commencing Activities to Restart Operations at the Aguablanca Project in Spain
-
American Tungsten Provides Update on Site Rehabilitation Progress and Federal Engagement
-
Papa Johns Canada Brings Hawaii Home with The Aloha Trio
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
BioCryst Announces Departure of Dr. Helen Thackray
-
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
-
Rocky Shore Gold Announces Non-Brokered Private Placement
-
IICRC guidelines identify new standard of care for fire and smoke restoration
-
Trina Storage Powers Latin America's Energy Transition as Flagship GWh-Scale Project Ships to Chile
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
WeightWatchers Announces Second Quarter 2025 Results
-
Powerfleet Drives SaaS Flywheel in Q1 FY2026: 6% Sequential Services Growth, Margin Expansion, and Strong Progress Towards Achieving its EBITDA Expansion Targets
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
-
Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds
-
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
-
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update
-
OpenText Announces Leadership Transition
-
AAON Reports Second Quarter 2025 Results
-
FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response
-
U.S. GoldMining Advances Planning With State of Alaska Officials for Critical Road Infrastructure to the Whistler Gold-Copper Project, Alaska
-
Alma Introduces PixelPeel™: A Smarter, Gentler Approach to Laser Skin Renewal
-
enCore Energy Reports Q2 2025 Financial Results, Highlighted by Increased Uranium Extraction Rates and Reduced Costs
-
Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments
-
Dream Factory of Brooklyn Celebrates 15 Years of Making Dreams Come True with Special Brooklyn Cyclones Charity Game
-
Ceva, Inc. Announces Second Quarter 2025 Financial Results
-
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
-
Senstar Technologies to Report Second Quarter 2025 Results on Monday, August 25, 2025
-
I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
-
Universal Pictures' "Nobody 2" to be Released with TrueCut Motion
-
Rural King Opens 11th Store in Pennsylvania, Expanding Access to Farm and Home Essentials

